Guardant Health Inc (GH)

Jul 23, 2025

What analysts say about Guardant Health Inc. stockFree Stock Selection - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What drives Guardant Health Inc. stock priceDynamic growth stocks - Autocar Professional

Jul 23, 2025

Jul 23, 2025

10 Best Mid Cap Pharma Stocks to Buy - Insider Monkey

Jul 23, 2025

Jul 23, 2025

Colonoscopies are no fun. These at-home colon cancer screenings offer a shortcut. - Business Insider

Jul 23, 2025

Jul 23, 2025

Guardant Health Inc. Stock Analysis and ForecastFree Capital Allocation Plans - jammulinksnews.com

Jul 23, 2025

Jul 23, 2025

3 Reasons to Avoid GH and 1 Stock to Buy Instead - Yahoo Finance

Jul 23, 2025

Jul 22, 2025

Is Guardant Health Inc. a good long term investmentFree Consultation - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Cathie Wood’s ARK ETFs shift focus, buying NVIDIA and selling GUARDANT - Investing.com

Jul 22, 2025

Jul 21, 2025

Freenome's new CEO is ready to compete in race for tests that can detect cancer earlySan Francisco Business Times - The Business Journals

Jul 21, 2025

Jul 19, 2025

Cathie Wood's Ark Invest Offloads Meta, Loads Up On Teradyne, Caris Life Sciences - Benzinga

Jul 19, 2025

Jul 18, 2025

Guardant Health (GH): director Tariq Musa sells $5591 in stock By Investing.com - Investing.com South Africa

Jul 18, 2025

Jul 18, 2025

Guardant Health (GH): director Tariq Musa sells $5591 in stock - Investing.com

Jul 18, 2025

Jul 18, 2025

Guardant Health Director Sells 142 Shares at $48.2 Per Share on 2025-07-17. - AInvest

Jul 18, 2025

Jul 16, 2025

Global Liquid Biopsy Market Size Worth USD 25.24 Billion By 2032 | - openPR.com

Jul 16, 2025

Jul 16, 2025

Lung Cancer Diagnostics Market Expansion Driven by Liquid - openPR.com

Jul 16, 2025

Jul 16, 2025

(GH) Technical Data - news.stocktradersdaily.com

Jul 16, 2025

Jul 15, 2025

User - FinancialContent

Jul 15, 2025

Jul 15, 2025

Evercore ISI Keeps Their Buy Rating on Guardant Health (GH) - The Globe and Mail

Jul 15, 2025

Jul 15, 2025

Guardant Health to Report Second Quarter 2025 Financial Results on July 30, 2025 - BioSpace

Jul 15, 2025

Jul 14, 2025

Guardant Health stock price target maintained at $60 by Evercore ISI - Investing.com Canada

Jul 14, 2025

Jul 14, 2025

What makes Guardant Health Inc. stock price move sharplyFree Stock Portfolio Optimization - beatles.ru

Jul 14, 2025

Jul 14, 2025

Press Release: Guardant Health to Report Second Quarter 2025 Financial Results on July 30, 2025 - 富途牛牛

Jul 14, 2025

Jul 11, 2025

Quinn Emanuel Sanctioned For Ad Case 'Misrepresentations' - Law360

Jul 11, 2025

Jul 11, 2025

Guardant Health, Gilead Sciences, Inspire Medical Systems, Enovis, and AMN Healthcare Services Stocks Trade Down, What You Need To Know - MSN

Jul 11, 2025

Jul 11, 2025

US judge rebukes law firm Quinn Emanuel, awards $3 million sanction in Guardant case - Reuters

Jul 11, 2025

Jul 10, 2025

East Bay company looks to bring cancer insights to rheumatoid arthritisSan Francisco Business Times - The Business Journals

Jul 10, 2025

Jul 08, 2025

Precision Medicine Market worth $246.66 billion by 2029 with 11.1% CAGRRIVER COUNTRY - RIVER COUNTRY - NEWS CHANNEL NEBRASKA

Jul 08, 2025

Jul 03, 2025

Guardant Health Insider Sold Shares Worth $5,087,630, According to a Recent SEC Filing - MarketScreener

Jul 03, 2025

Jun 30, 2025

The 5 Most Interesting Analyst Questions From Guardant Health’s Q1 Earnings Call - Yahoo Finance

Jun 30, 2025

Jun 27, 2025

Is GH's Q1 2025 forecast achievable? - AInvest

Jun 27, 2025

Jun 27, 2025

Exas, Guardant, Gilead among gainers as Supreme Court ensures free preventive care - MSN

Jun 27, 2025

Jun 27, 2025

A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer - The Lancet

Jun 27, 2025

Jun 27, 2025

Guardant Health’s Colorectal Cancer Screening Test Earns Another Honor - Medical Product Outsourcing

Jun 27, 2025

Jun 26, 2025

Precision Medicine: The Future of Healthcare? Companies Like Tempus AI, Guardant Health, and Exact Sciences Are Pioneering the Way - AInvest

Jun 26, 2025

Jun 25, 2025

Could Personalized Medicine Be Your Portfolio's Next Big Winner? Find Out - Benzinga

Jun 25, 2025

Jun 24, 2025

Guardant Health gets Breakthrough Device Designation from FDA for cancer detection test - Mugglehead Magazine

Jun 24, 2025